Idiopathic pulmonary fibrosis - Wikipedia
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial - The Lancet Respiratory Medicine
Idiopathic Pulmonary Fibrosis (IPF) - Renstar Medical Research
Phase IV IPF Clinical Trials | ILD Collaborative
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM
Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN
.png "REMAP-ILD: The future of clinical trials in pulmonary fibrosis – Action for Pulmonary Fibrosis")
REMAP-ILD: The future of clinical trials in pulmonary fibrosis – Action for Pulmonary Fibrosis
Timeline for landmark trials for antifibrotic therapy for idiopathic... | Download Scientific Diagram
Global Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Highlights - 2022
Ongoing clinical trials in idiopathic pulmonary fibrosis | Download Table
Recent Clinical Trials on Idiopathic Pulmonary Fibrosis | Download Table
Targeting fibrosis: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Idiopathic Pulmonary Fibrosis Disease - Global Clinical Trials Review, H2, 2020
Idiopathic Pulmonary Fibrosis Disease - Global Clinical Trials Review, H2, 2020
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development | SpringerLink
Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme | Respiratory Research | Full Text
Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns and current practices - Mayo Clinic
Frontiers | Challenges for Clinical Drug Development in Pulmonary Fibrosis
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years | European Respiratory Society
